C. Shibasaki

Pre-immunization of donor lymphocytes with GITR agonistic antibody enhances antitumor immunity in autologous hematopoietic stem cell transplantation.

K. Aoki, Yukihiro Mizoguchi, K. Narumi, 2019, Biochemical and biophysical research communications.

Local Administration of GITR Agonistic Antibody Induces a Stronger Antitumor Immunity than Systemic Delivery

Teruhiko Yoshida, N. Hiraoka, K. Aoki, 2019, Scientific Reports.

The nature of in vivo cell-killing of deoxyspergualin, and its implication in combination with other antitumor agents.

T. Takeuchi, K. Takahashi, K. Nishikawa, 1991, The Journal of antibiotics.

Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.

M. Arakawa, T. Takeuchi, K. Takahashi, 1991, The Journal of antibiotics.

Local Administration of GITR Agonistic Antibody Induces a Stronger Antitumor Immunity than Systemic Delivery

Teruhiko Yoshida, N. Hiraoka, K. Aoki, 2019, Scientific Reports.

Antitumor activity of spergualin, a novel antitumor antibiotic.

T. Takeuchi, H. Umezawa, K. Takahashi, 1986, Journal of antibiotics (Tokyo. 1968).

Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.

T. Takeuchi, H. Umezawa, K. Takahashi, 1987, Cancer research.

Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression

K. Aoki, H. Hashimoto, K. Narumi, 2018, Cancer Gene Therapy.

Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression

K. Aoki, K. Narumi, Aya Hirata, 2018, Cancer Gene Therapy.